A-Alpha Bio vs SyntheX

A-Alpha Bio logo

A-Alpha Bio

The protein-protein interaction company

50 employees · est. 2017 · Seattle, United States

VS
SyntheX logo

SyntheX

Targeting the undruggable with synthetic biology-based drug discovery platforms

26 employees · est. 2016 · San Francisco, United States

SyntheX is the older company (2017 vs 2016).

Side-by-Side Comparison

A-Alpha Bio SyntheX
Founded
2017 2016 older
Headquarters
Seattle, United States San Francisco, United States
Employees
50 26
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Grant Venture round
Total Funding
$64.05M $11.58M
Funding Rounds
9 6
Services
Quantitative Characterization of Protein Interactions, Machine Learning Model Development for Biology, Platform for Drug Discovery and Optimization Not tracked yet
Target Customers
Pharmaceutical Companies, Biotechnology Firms, Research Institutions, Healthcare Organizations Not tracked yet
Taxonomy
Protein-Protein InteractionsAlphaSeq TechnologyAlphaBind AI PlatformBiotechnology PlatformDrug DiscoveryProtein Engineering +9 Synthetic BiologyDrug DiscoveryOncologyGenetic EngineeringProtein-Protein InteractionsTargeted Protein Degradation +8
Website
aalphabio.com synthexlabs.com
A-Alpha Bio logo

About A-Alpha Bio

A-Alpha Bio, known as "The protein-protein interaction company," is a pioneering entity in the biotechnology industry focused on the large-scale measurement, prediction, and engineering of protein-protein interactions. Founded in 2017 and based in the United States, this innovative company utilizes...

SyntheX logo

About SyntheX

SyntheX is a biotechnology and pharmaceutical startup founded in 2016 in the United States. The company's slogan "Targeting the undruggable with synthetic biology-based drug discovery platforms" encapsulates its focus on utilizing synthetic biology to revolutionize drug discovery. SyntheX's approach...

Also comparing in this category

Comparing more than these two?

Get A-Alpha Bio, SyntheX and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does A-Alpha Bio compare?

A PDF of A-Alpha Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

A-Alpha Bio was founded in 2017, based in Seattle, United States, with 50 employees. A-Alpha Bio, known as "The protein-protein interaction company," is a pioneering entity in the biotechnology industry focused on the large-scale measurement, prediction, and engineering of protein-pro. SyntheX was founded in 2016, based in San Francisco, United States, with 26 employees. SyntheX is a biotechnology and pharmaceutical startup founded in 2016 in the United States. The company's slogan "Targeting the undruggable with synthetic biology-based drug discovery platforms" encap.
A-Alpha Bio has raised $64.05M and SyntheX $11.58M. Latest stage: A-Alpha Bio Grant, SyntheX Venture round.
Both work in Biotechnology, Health and Wellness and Life Sciences and list protein-protein interactions, drug discovery and synthetic biology among their focus areas.

Compare A-Alpha Bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at A-Alpha Bio on 15 Jun 2026, and SyntheX on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes